Johnson & Johnson Stock Jumps 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September
The pharmaceutical company has signed an agreement with the US government's Biomedical Advanced Research and Development Authority to invest $1 billion in the effort, it said in a statement on Monday.